100 mg Resmetirom Tablet
MGL-3196-21
Phase 1 small_molecule completed
Quick answer
100 mg Resmetirom Tablet for Renal Impairment is a Phase 1 program (small_molecule) at MADRIGAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MADRIGAL PHARMACEUTICALS, INC.
- Indication
- Renal Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed